Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is an oligodendroglioma?

Peter C Burger1

  • 1Department of Pathology, Johns Hopkins University Hospital, Baltimore, Md, USA.

Brain Pathology (Zurich, Switzerland)
|April 18, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.

Neuro-oncology·2025
Same author

AZD8055 enhances in vivo efficacy of afatinib in chordomas.

The Journal of pathology·2021
Same author

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021
Same author

Reply to S.A. Upadhyaya.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020
Same author

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020
Same author

Chromosomal defects track tumor subpopulations and change in progression in oligodendroglioma.

Convergent science physical oncology·2019